This effect was similarly observed in MINAS patients with two PV in breast cancer genes (ATM, BRCA1, BRCA2, CHEK2, NBN) which are known to increase breast cancer risk at a younger age, and in some cases can also be accompanied by multiple malignancies [15–17]. This evidence concerns the gene CHEK2 and breast carcinoma.